0
0
0
0
1
2
3
$0
Is Viatris solid or fragile? The Finex Financial Health Scanner reads VTRS's real financial statements and scores its debt, liquidity, margins, cash flow and growth, with the Altman Z-score, the Piotroski F-score and the red flags explained in plain words.
| Revenue (FY2025) | $14.3B |
|---|---|
| Net income | -$3.5B |
| Operating margin | -18.6% |
| Net margin | -24.6% |
| Cash and investments | $1.3B |
| Total debt | $14.4B |
| Free cash flow | $3.2B |
| Revenue growth (1 year) | -3.0% |
Data: Nasdaq and Yahoo Finance. Educational, not financial advice.